Measurement of brain metabolites by 1H magnetic resonance spectroscopy in patients with schizophrenia: a systematic review and meta-analysis (Q31001850)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Measurement of brain metabolites by 1H magnetic resonance spectroscopy in patients with schizophrenia: a systematic review and meta-analysis	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

28 June 2017

0 references

1 reference

Europe PubMed Central

Measurement of brain metabolites by 1H magnetic resonance spectroscopy in patients with schizophrenia: a systematic review and meta-analysis (English)

1 reference

Europe PubMed Central

28 June 2017

0 references

0 references

0 references

systematic review

1 reference

based on heuristic

inferred from title

Jeffrey Lieberman

3

object named as

Jeffrey A Lieberman

1 reference

Europe PubMed Central

28 June 2017

author name string

R Grant Steen

1

1 reference

Europe PubMed Central

28 June 2017

Robert M Hamer

2

1 reference

Europe PubMed Central

28 June 2017

language of work or name

0 references

publication date

1 November 2005

1 reference

Europe PubMed Central

28 June 2017

Neuropsychopharmacology

1 reference

Europe PubMed Central

28 June 2017

30

1 reference

Europe PubMed Central

28 June 2017

11

1 reference

Europe PubMed Central

28 June 2017

1949-1962

1 reference

Europe PubMed Central

28 June 2017

Neural damage in the lenticular nucleus linked with tardive dyskinesia in schizophrenia: a preliminary study using proton magnetic resonance spectroscopy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300850

21 January 2018

Neuropsychological correlates of basal ganglia and medial temporal lobe NAA/Cho reductions in traumatic brain injury

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300850

21 January 2018

Reduced NAA in the thalamus and altered membrane and glial metabolism in schizophrenic patients detected by 1H-MRS and tissue segmentation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300850

21 January 2018

A short echo proton magnetic resonance spectroscopy study of the left mesial-temporal lobe in first-onset schizophrenic patients.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300850

21 January 2018

Measurement of glutamate and glutamine in the medial prefrontal cortex of never-treated schizophrenic patients and healthy controls by proton magnetic resonance spectroscopy.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300850

21 January 2018

Magnetic resonance spectroscopy and imaging of the thalamus in idiopathic generalized epilepsy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300850

21 January 2018

Regionally specific neuronal pathology in untreated patients with schizophrenia: a proton magnetic resonance spectroscopic imaging study.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300850

21 January 2018

The effect of treatment with antipsychotic drugs on brain N-acetylaspartate measures in patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300850

21 January 2018

Reproducibility of proton magnetic resonance spectroscopic imaging in patients with schizophrenia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300850

21 January 2018

Specific relationship between prefrontal neuronal N-acetylaspartate and activation of the working memory cortical network in schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300850

21 January 2018

Common pattern of cortical pathology in childhood-onset and adult-onset schizophrenia as identified by proton magnetic resonance spectroscopic imaging.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300850

21 January 2018

Regionally specific pattern of neurochemical pathology in schizophrenia as assessed by multislice proton magnetic resonance spectroscopic imaging.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300850

21 January 2018

Working memory deficits and levels of N-acetylaspartate in patients with schizophreniform disorder

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300850

21 January 2018

Proton magnetic resonance spectroscopy in schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300850

21 January 2018

N-acetyl-L-aspartic acid: a literature review of a compound prominent in 1H-NMR spectroscopic studies of brain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300850

21 January 2018

Favorable effect on neuronal viability in the anterior cingulate gyrus due to long-term treatment with atypical antipsychotics: an MRSI study.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300850

21 January 2018

Functioning and neuronal viability of the anterior cingulate neurons following antipsychotic treatment: MR-spectroscopic imaging in chronic schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300850

21 January 2018

Frontal lobe of children with schizophrenia spectrum disorders: a proton magnetic resonance spectroscopic study.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300850

21 January 2018

1H-magnetic resonance spectroscopy of the left temporal and frontal lobes in schizophrenia: clinical, neurodevelopmental, and cognitive correlates.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300850

21 January 2018

Effects of chronic haloperidol and clozapine treatments on frontal and caudate neurochemistry in schizophrenia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300850

21 January 2018

Longitudinal follow-up of neurochemical changes during the first year of antipsychotic treatment in schizophrenia patients with minimal previous medication exposure.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300850

21 January 2018

High choline concentrations in the caudate nucleus in antipsychotic-naive patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300850

21 January 2018

Selective Relationship Between PrefrontalN-Acetylaspartate Measures and Negative Symptoms in Schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300850

21 January 2018

Hippocampal N-acetyl aspartate in unaffected siblings of patients with schizophrenia: a possible intermediate neurobiological phenotype.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300850

21 January 2018

Proton magnetic resonance spectroscopy of the frontal lobe and cerebellar vermis in children with a mood disorder and a familial risk for bipolar disorders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300850

21 January 2018

Proton magnetic resonance spectroscopy in the frontal and temporal lobes of neuroleptic naive patients with schizophrenia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300850

21 January 2018

1H magnetic resonance spectroscopy characterization of neuronal dysfunction in drug-naive, chronic schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300850

21 January 2018

Increased thalamic N-acetylaspartate in male patients with familial bipolar I disorder

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300850

21 January 2018

Evidence for altered cerebellar vermis neuronal integrity in schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300850

21 January 2018

Reduced hippocampal N-acetylaspartate without volume loss in schizophrenia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300850

21 January 2018

Decreased left frontal lobe N-acetylaspartate in schizophrenia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300850

21 January 2018

Hippocampal neuronal dysfunction in schizophrenia as measured by proton magnetic resonance spectroscopy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300850

21 January 2018

Proton magnetic resonance spectroscopy of the anterior cingulate region in schizophrenia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300850

21 January 2018

Proton magnetic resonance spectroscopy (1H MRS) in schizophrenia: investigation of the right and left hippocampus, thalamus, and prefrontal cortex.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300850

21 January 2018

Longitudinal quantitative proton magnetic resonance spectroscopy of the hippocampus in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300850

21 January 2018

Single-voxel proton magnetic resonance spectroscopy of the pons and cerebellum in patients with schizophrenia: a preliminary study.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300850

21 January 2018

Lower concentration of thalamic n-acetylaspartate in patients with schizophrenia: a replication study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300850

21 January 2018

Multiregional 1H-MRSI of the hippocampus, thalamus, and basal ganglia in schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300850

21 January 2018

Selective deficit of hippocampal N-acetylaspartate in antipsychotic-naive patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300850

21 January 2018

Proton magnetic resonance spectroscopy of the left medial temporal and frontal lobes in chronic schizophrenia: preliminary report.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300850

21 January 2018

Spectroscopic axonal damage of the right locus coeruleus relates to selective attention impairment in early stage relapsing-remitting multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300850

21 January 2018

Use of proton magnetic resonance spectroscopy of the brain to differentiate gliomatosis cerebri from low-grade glioma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300850

21 January 2018

Basal ganglia N-acetylaspartate correlates with the performance in the procedural task 'Tower of Hanoi' of neuroleptic-naive schizophrenic patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300850

21 January 2018

Brainstem neurodegeneration correlates with clinical dysfunction in SCA1 but not in SCA2. A quantitative volumetric, diffusion and proton spectroscopy MR study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300850

21 January 2018

Proton magnetic resonance spectroscopy of the inferior frontal gyrus and thalamus and its relationship to verbal learning task performance in patients with schizophrenia: a preliminary report

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300850

21 January 2018

Regional proton magnetic resonance spectroscopy in schizophrenia and exploration of drug effect.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300850

21 January 2018

Recovery of N-acetylaspartate in corticomotor neurons of patients with ALS after riluzole therapy.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300850

21 January 2018

In vivo neurochemistry of the brain in schizophrenia as revealed by magnetic resonance spectroscopy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300850

21 January 2018

Brain metabolite concentration ratios in vivo: multisite reproducibility by single-voxel 1H MR spectroscopy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300850

21 January 2018

Magnetic resonance spectroscopy: current and future applications in psychiatric research

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300850

21 January 2018

Hippocampal age-related changes in schizophrenia: a proton magnetic resonance spectroscopy study.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300850

21 January 2018

Canavan disease: from spongy degeneration to molecular analysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300850

21 January 2018

Reduced brain N-acetylaspartate suggests neuronal loss in cognitively impaired human immunodeficiency virus-seropositive individuals: in vivo 1H magnetic resonance spectroscopic imaging

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300850

21 January 2018

Preoperative brain injury in newborns with transposition of the great arteries

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300850

21 January 2018

Mesial temporal lobe Cho to Cr(PCr) ratio asymmetry in chronic schizophrenics

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300850

21 January 2018

Reproducibility of 1H-MRS measurements in schizophrenic patients.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300850

21 January 2018

Asperger syndrome: a proton magnetic resonance spectroscopy study of brain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300850

21 January 2018

Proton magnetic resonance spectroscopy of lenticular nuclei in simple schizophrenia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300850

21 January 2018

In vitro 1H-magnetic resonance spectroscopy of postmortem brains with schizophrenia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300850

21 January 2018

1H MRSI evidence of metabolic abnormalities in childhood-onset schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300850

21 January 2018

Proton MR spectroscopy in multiple sclerosis: value in establishing diagnosis, monitoring progression, and evaluating therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300850

21 January 2018

Clinical correlation of striatal 1H MRS changes in Huntington's disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300850

21 January 2018

Different patterns of N-acetylaspartate loss in subcortical ischemic vascular dementia and AD.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300850

21 January 2018

Proton magnetic resonance spectroscopy of the brain in schizophrenic and affective patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300850

21 January 2018

A review of MRI findings in schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300850

21 January 2018

Proton magnetic resonance spectroscopy in children with moyamoya disease.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300850

21 January 2018

Proton magnetic resonance spectroscopy of the basal ganglia in patients with schizophrenia: a preliminary report.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300850

21 January 2018

Frontal lobe N-acetylaspartate correlates with psychopathology in schizophrenia: a proton magnetic resonance spectroscopy study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300850

21 January 2018

Differences in fMRI and MRS in a monozygotic twin pair discordant for schizophrenia (case report).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300850

21 January 2018

Diffusion tensor imaging (DTI) and proton magnetic resonance spectroscopy (1H MRS) in schizophrenic subjects and normal controls

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300850

21 January 2018

Brain N-acetylaspartate is elevated in Pelizaeus-Merzbacher disease with PLP1 duplication

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300850

21 January 2018

The relationship between diffuse axonal damage and fatigue in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300850

21 January 2018

Glutamate and glutamine in the anterior cingulate and thalamus of medicated patients with chronic schizophrenia and healthy comparison subjects measured with 4.0-T proton MRS.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300850

21 January 2018

Glutamate and glutamine measured with 4.0 T proton MRS in never-treated patients with schizophrenia and healthy volunteers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300850

21 January 2018

Preliminary study of frontal lobe 1H MR spectroscopy in childhood-onset schizophrenia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300850

21 January 2018

Magnetic resonance spectroscopy in AD.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300850

21 January 2018

Evidence of neuronal injury outside the medial temporal lobe in temporal lobe epilepsy: N-acetylaspartate concentration reductions detected with multisection proton MR spectroscopic imaging--initial experience

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300850

21 January 2018

Low-grade gliomas and focal cortical developmental malformations: differentiation with proton MR spectroscopy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300850

21 January 2018

A fully automated method for tissue segmentation and CSF-correction of proton MRSI metabolites corroborates abnormal hippocampal NAA in schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300850

21 January 2018

1H-MR spectroscopy and gray matter volume of the anterior cingulate cortex in schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300850

21 January 2018

Proton magnetic resonance spectroscopy of the temporal lobes in schizophrenics and normal controls.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300850

21 January 2018

Reversible decreases in N-acetylaspartate after acute brain injury

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300850

21 January 2018

Decreased frontal lobe ratio of N-acetyl aspartate to choline in familial schizophrenia: a proton magnetic resonance spectroscopy study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300850

7 January 2021

based on heuristic

inferred from DOI database lookup

Observation of metabolic changes in chronic schizophrenia after neuroleptic treatment by in vivo hydrogen magnetic resonance spectroscopy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300850

7 January 2021

based on heuristic

inferred from DOI database lookup

Reduced concentrations of thalamic N-acetylaspartate in male patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300850

7 January 2021

based on heuristic

inferred from DOI database lookup

Proton magnetic resonance spectroscopy of the medial prefrontal cortex in patients with deficit schizophrenia: preliminary report

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300850

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of age, medication, and illness duration on the N-acetyl aspartate signal of the anterior cingulate region in schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300850

7 January 2021

based on heuristic

inferred from DOI database lookup

Proton magnetic resonance spectroscopy of basal ganglia in chronic schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300850

7 January 2021

based on heuristic

inferred from DOI database lookup

Subtype-associated metabolite differences in the temporal lobe in schizophrenia detected by proton magnetic resonance spectroscopy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300850

7 January 2021

based on heuristic

inferred from DOI database lookup

Heritability heightens brain metabolite differences in schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300850

7 January 2021

based on heuristic

inferred from DOI database lookup

Hippocampal pathology in schizophrenia: magnetic resonance imaging and spectroscopy studies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300850

7 January 2021

based on heuristic

inferred from DOI database lookup

Proton magnetic resonance spectroscopy: an in vivo method of estimating hippocampal neuronal depletion in schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300850

7 January 2021

based on heuristic

inferred from DOI database lookup

Proton magnetic resonance spectroscopy (1H MRS) of the hippocampal formation in schizophrenia: a pilot study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300850

7 January 2021

based on heuristic

inferred from DOI database lookup

Thalamic abnormalities in patients with schizophrenia revealed by proton magnetic resonance spectroscopy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300850

7 January 2021

based on heuristic

inferred from DOI database lookup

Correlation of basal ganglia magnetic resonance spectroscopy with Apgar score in perinatal asphyxia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300850

7 January 2021

based on heuristic

inferred from DOI database lookup

Temporal lobe proton magnetic resonance spectroscopy of patients with first-episode psychosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300850

7 January 2021

based on heuristic

inferred from DOI database lookup

An in vivo proton magnetic resonance spectroscopy study of schizophrenia patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300850

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.NPP.1300850

1 reference

Europe PubMed Central

28 June 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

28 June 2017

ResearchGate publication ID

0 references

Springer Nature article ID

10.1038/sj.npp.1300850

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q31001850&oldid=2055587717"